Suggestions
Carly Stockdale
CEO and co-founder of BestLife
Carly Rose Stockdale is the co-founder and CEO of BestLife at Cenegenics, a prominent fertility center in the Bay Area. She is known for her dedication to prioritizing patient care and experience in the healthcare sector, particularly in fertility and women's health.
Carly's educational background includes a Bachelor's degree from Yale University and further studies in Public Health at the Yale School of Public Health. Her professional experience is diverse, encompassing roles such as:
- Vice President of Commercial Operations at Prelude Fertility
- CEO and Chairperson of the Board of Directors at ChartRequest
- Senior Consultant at ECG Management Consultants
- EIR at Morgan Stanley
- Finance Fellow at Massachusetts General Hospital
- Analyst at Compass Strategic Consulting
Additionally, Carly has been involved as an investor or advisor to startups, showcasing her entrepreneurial spirit and interest in fostering innovation.
Carly Stockdale can be reached at 415.964.5618 or via email at [email protected]. She is also active on social media platforms such as Instagram and Facebook under the handle @springfertility.
Highlights
Imagine a world where your family's future is not yours to decide.
Enabling healthy babies on families' chosen timelines has been a defining aim of my professional life. So Alabama's arbitrary legal move to restrict access to IVF shocked me.
And it's personal. If other states were to follow this judgment, or the Pope's recent call for a global ban on surrogacy, my and Tom's family would not exist.
Of course supporting IVF for those who cannot conceive is kind. It is undeniable anguish for those affected. I'd bet this Alabama judge, and the Pope for that matter, have not personally experienced it.
But even if you lack empathy for the global 17.5% that suffer from infertility, there is the reality that our global fertility rate is declining. From 5 babies per woman in 1950 to a projected 1.8 by 2050, we're facing demographic problems that could upend economies falling below the replacement rate.
It's worth understanding how the US led in reproductive innovation over the last 35 years. It was by blending cutting-edge science and third party reproduction with the legal safeguards necessary to protect it. This does not exist elsewhere in the world.
The battle for #IVF #access, #surrogacy and #reproductive #longevity isn't just about morality or rights. It's about shaping the future, where ignoring the science of human biology and demographic trends has consequences. Japan and China's empty cities and aging populations are a warning.
Shoutout to the champions of reproductive medicine who are in this. We must resist ideology stifling innovation and population growth - the stakes couldn't be higher personally or politically.
cc RESOLVE: The National Infertility Association American Society for Reproductive Medicine - ASRM David Sable Peter Klatsky Rebecca Silver Anna Luisa Schaffgotsch Daniel Shapiro Andrew Toledo Cara Reymann Brian Klein David Stern Alexander Bisignano Brian E. Miller Lucky Sekhon, M.D. Joan-Carles Arce Richard Jennings
Fundraise announcements get the exclusives but the triumphs are earned over the course of many challenges! Perennially proud of my husband Tom Griffiths, his co-founder Savina Perez and the Hone team for building something really important with a bench of fantastic investors and customers.
